Cargando…
Overview of the Development and Use of Akt Inhibitors in Prostate Cancer
Deregulation of the PI3K-Akt-mTOR pathway plays a critical role in the development and progression of many cancers. In prostate cancer, evidence suggests that it is mainly driven by PTEN loss of function. For many years, the development of selective Akt inhibitors has been challenging. In recent pha...
Autores principales: | Gasmi, Anis, Roubaud, Guilhem, Dariane, Charles, Barret, Eric, Beauval, Jean-Baptiste, Brureau, Laurent, Créhange, Gilles, Fiard, Gaëlle, Fromont, Gaëlle, Gauthé, Mathieu, Ruffion, Alain, Renard-Penna, Raphaële, Sargos, Paul, Rouprêt, Morgan, Ploussard, Guillaume, Mathieu, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745410/ https://www.ncbi.nlm.nih.gov/pubmed/35011901 http://dx.doi.org/10.3390/jcm11010160 |
Ejemplares similares
-
Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
por: Gauthé, Mathieu, et al.
Publicado: (2021) -
Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review
por: Manceau, Cécile, et al.
Publicado: (2021) -
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
por: Baboudjian, Michael, et al.
Publicado: (2022) -
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers
por: Teyssonneau, Diego, et al.
Publicado: (2022) -
Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d’Urologie
por: Sargos, Paul, et al.
Publicado: (2021)